Drug profile · INN
hetrombopag
hetrombopag is a thrombopoietin receptor agonist.
NMPA: clinical trials
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — hetrombopag
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.70
Quick answer
hetrombopag is a thrombopoietin receptor agonist.
Key facts
INN hetrombopag
Mechanism Thrombopoietin receptor agonist
Target Thrombopoietin receptor
Mechanism of action
Thrombopoietin receptor agonist
Primary target: Thrombopoietin receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is hetrombopag?
hetrombopag is a thrombopoietin receptor agonist.